(Q35575495)

8 August 2017

1 reference

title

IBD and the gut microbiota--from bench to personalized medicine (English)

1 reference

8 August 2017

personalized medicine

1 reference

inferred from title

author name string

Emanuelle Bellaguarda

series ordinal

1

1 reference

PubMed ID

25762474

8 August 2017

Eugene B Chang

series ordinal

2

1 reference

8 August 2017

1 April 2015

1 reference

Current gastroenterology reports

8 August 2017

1 reference

8 August 2017

17

1 reference

8 August 2017

4

1 reference

8 August 2017

15

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-015-0439-z

8 August 2017

0 references

cites work

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

The economic burden of inflammatory bowel disease: clear problem, unclear solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Inflammatory bowel disease epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

New IBD genetics: common pathways with other diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Role of the microbiome in energy regulation and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Gut microbiota and allergic disease: new findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

The Human Microbiome Project in 2011 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Viruses in the faecal microbiota of monozygotic twins and their mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Nod2 is required for the regulation of commensal microbiota in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

A Nonsynonymous SNP in ATG16L1 Predisposes to Ileal Crohn’s Disease and Is Independent of CARD15 and IBD5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Evolution of mammals and their gut microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Alterations in the gut microbiome of children with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

The treatment-naive microbiome in new-onset Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Succession of microbial consortia in the developing infant gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Role of the gut microbiota in human nutrition and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Gut immune maturation depends on colonization with a host-specific microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Modulation of immune homeostasis by commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Desulfovibrio bacterial species are increased in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Microbial pathways in colonic sulfur metabolism and links with health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Host-derived nitrate boosts growth of E. coli in the inflamed gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

The effect of Saccharomyces boulardii on human colon cells and inflammation in rats with trinitrobenzene sulfonic acid-induced colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Saccharomyces boulardii does not prevent relapse of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

The human microbiome: ecosystem resilience and health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Antibiotic exposure and IBD development among children: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Unravelling the effects of the environment and host genotype on the gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Patient perceptions of fecal microbiota transplantation for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

Dysbiosis in inflammatory bowel disease: a role for bacteriophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0439-Z

21 January 2018

1 reference

12 December 2020

TREATMENT OF ULCERATIVE COLITIS BY IMPLANTATION OF NORMAL COLONIC FLORA

1 reference

12 December 2020

Current concepts on the immunopathogenesis of inflammatory bowel disease

1 reference

12 December 2020

1 reference

12 December 2020

Clinical guidelines for the management of pouchitis

1 reference

12 December 2020

Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.

1 reference

12 December 2020

A patient with severe Crohn's colitis responds to Faecal Microbiota Transplantation

1 reference

12 December 2020

Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease

1 reference

12 December 2020

Advances in IBD genetics

1 reference

12 December 2020

Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice

1 reference

12 December 2020

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease

1 reference

12 December 2020

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

12 December 2020

Epidemiology of inflammatory bowel diseases in iran and Asia; a mini review.

1 reference

12 December 2020

Addition of Metronidazole to Azathioprine for the Prevention of Postoperative Recurrence of Crohn’s Disease

1 reference

12 December 2020

The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models

1 reference

12 December 2020

DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells.

1 reference

12 December 2020

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

1 reference

12 December 2020

Metronidazole therapy for Crohn's disease and associated fistulae.

1 reference

12 December 2020

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

12 December 2020

Metronidazole therapy for perineal Crohn's disease: a follow-up study

1 reference

12 December 2020

Studies on the Transformation of the Intestinal Flora, with Special Reference to the Implantation of Bacillus Acidophilus: I. Feeding Experiments with Albino Rats

1 reference

12 December 2020

10.1007/S11894-015-0439-Z

Identifiers

DOI

1 reference

8 August 2017

1 reference

PubMed ID

25762474